Supply Pain
As more ATMPs progress towards the market, there are significant emergent challenges to the supply chain. What needs to happen to ensure therapies are effectively and efficiently produced?
FACILITATED BY
SHARON BROWNLOW | Chief Business Officer | Cell & Gene Therapy Catapult
PANELLISTS INCLUDE
ROBERT JONES | Vice President, Global BioServices | Cryoport Systems
MARK FOWLER | Global Head of Procurement | Autolus
DAN PEARCE | Vice President, European Manufacturing & Technical Operations | Adaptimmune
SADIA L’BAOUCH | Chief Technical Officer, Vice President | Ixaka